TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06275529

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transforaminal Epidural Steroid Injection
Description: Epidural injections have been used since about 1900 for the treatment of low back and lower extremity pain, with steroids added to local anesthetics in about 1950. The epidural space can be entered by 3 approaches: caudal, interlaminar, and transforaminal. Transforaminal Epidural Steroid Injections:~After the patient is monitored in pron position and asepsis is ensured, the epidural space is entered with the appropriate needle through the transforaminal space by giving the necessary angles to the fluoroscopy. Then the location is confirmed with radiopaque agent and steroid injection is performed. The procedure takes 15-20 minutes.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transforaminal Epidural Steroid Injection
Description: Epidural injections have been used since about 1900 for the treatment of low back and lower extremity pain, with steroids added to local anesthetics in about 1950. The epidural space can be entered by 3 approaches: caudal, interlaminar, and transforaminal. Transforaminal Epidural Steroid Injections:~After the patient is monitored in pron position and asepsis is ensured, the epidural space is entered with the appropriate needle through the transforaminal space by giving the necessary angles to the fluoroscopy. Then the location is confirmed with radiopaque agent and steroid injection is performed. The procedure takes 15-20 minutes.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transforaminal Epidural Steroid Injection
Description: Epidural injections have been used since about 1900 for the treatment of low back and lower extremity pain, with steroids added to local anesthetics in about 1950. The epidural space can be entered by 3 approaches: caudal, interlaminar, and transforaminal. Transforaminal Epidural Steroid Injections:~After the patient is monitored in pron position and asepsis is ensured, the epidural space is entered with the appropriate needle through the transforaminal space by giving the necessary angles to the fluoroscopy. Then the location is confirmed with radiopaque agent and steroid injection is performed. The procedure takes 15-20 minutes.
Study: NCT04934631

Intervention type: OTHER
Intervention: Recording of CBT-ED session.
Description: Therapists will deliver treatment as usual (CBT-ED) to eating disorder patients. Therapy session will be audio recorded.

Intervention type: OTHER
Intervention: Recording of CBT-ED session.
Description: Therapists will deliver treatment as usual (CBT-ED) to eating disorder patients. Therapy session will be audio recorded.

Intervention type: OTHER
Intervention: Assessment of CBT-ED clinician competence.
Description: Independent raters will assess CBT-ED competence using the Cognitive-Behavioural Therapy Scale for Eating Disorders (CBTS-ED).
Study: NCT06131762

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Active release technique
Description: This include active release technique for 4 weeks

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Positional release technique
Description: This include positional release technique for 4 weeks
Study: NCT05260541

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 60 mg PRAX-114 or 40 mg PRAX-114
Description: Once daily oral treatment for 4 weeks

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Once daily oral treatment for 4 weeks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 40 mg PRAX-114
Description: Once daily oral treatment for 8 weeks
Study: NCT05411575

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Plerixafor 20 MG/ML [Mozobil]
Description: Plerixafor (Mozobil®) continuous intravenous infusion for 7 days

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo continuous intravenous infusion for 7 days
Study: NCT05195606

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Auditory stimulus
Description: Auditory stimulus will be applied to the patients in intervention group A. For the auditory stimulus, the sound recording of the relatives of the patients will be taken and the patients will be listened to with headphones.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Tactile stimulus
Description: Tactile stimulus will be applied to the patients in the intervention group B. The tactile stimulus will be performed by the researcher with a foot massage to be applied to the patient.
Study: NCT05308212

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Flu-M Tetra [Inactivated split influenza vaccine] w/p
Description: solution for intramuscular injection, 0.5 ml

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Flu-M Tetra [Inactivated split influenza vaccine] w/o/p
Description: solution for intramuscular injection, 0.5 ml

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Ultrix [Inactivated split influenza vaccine]
Description: solution for intramuscular injection, 0.5 ml
Study: NCT05846633

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: C mell treadmill
Description: C Mell treadmill provides Virtual Reality environment for rehabilitation with obstacles and motivational assistance

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: C mell treadmill
Description: C Mell treadmill provides Virtual Reality environment for rehabilitation with obstacles and motivational assistance
Study: NCT05832762

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endovascular treatment (EVT) + Best medical treatment (BMT)
Description: Endovascular treatment (EVT) in the experimental arm can be performed with any recanalization strategy based on the operator's choice, and anatomical and radiological situation: MT using aspiration or stent retriever, with or without stenting (CE-labelled) or angioplasty. In case of acute stenting, the use of antiplatelet drugs will be based on the operator's preference, anatomical situation, and risk of hemorrhage.~Best medical treatment (BMT) : Administration of drugs is at the treating physician's discretion (for example, intravenous fibrinolysis, anticoagulants, or antiplatelet agents) according to the local standards of care, but not intra-arterial therapies.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Best medical treatment (BMT)
Description: Administration of drugs is at the treating physician's discretion (for example, intravenous fibrinolysis, anticoagulants, or antiplatelet agents) according to the local standards of care, but not intra-arterial therapies.
Study: NCT05122130

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Melatonin
Description: The donor site will be dressed with melatonin loaded gelatin sponge

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Carbopol
Description: The donor site will be dressed with carbopol loaded gelatin sponge (placebo).
Study: NCT06382090

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laughter yoga
Description: This practice, which includes deep breathing exercises and laughter exercises, takes approximately 45 minutes. The sessions will be conducted by the principal investigator.
Study: NCT05242887

Intervention type: DIAGNOSTIC_TEST
Intervention: Delirium screening using 3D-CAM and UB-CAM
Description: Patients will be evaluated with 3D-CAM and UB-CAM by a trained examiner (geriatrician, resident or neuropsychologist). On the same day, they will be given a reference diagnosis of delirium based on DSM-V criteria by another trained examiner, blind to the results of the UB-CAM and 3D-CAM.
Study: NCT04725682

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tacrolimus
Description: a single dose of 1 mg capsule per period

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tacrolimus
Description: a single dose of 1 mg capsule per period
Study: NCT05904301

Intervention type: OTHER
Intervention: Usual medical management of patients, additional blood and stool samples for biobanking
Description: For all systemic diseases the following data will be collected:~Clinical examination, Laboratory data, Current medications, Constitution of biobanking.~For each disease:~Pathology specific Activity score, Global subjective disease activity by patient and by physician.
Study: NCT05184010

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ulnar nerve mini open release
Description: the ulnar nerve mini open release was performed before arthroscopic release for elbow

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: without ulnar nerve mini open release
Description: arthroscopic release for elbow stiffness alone without ulnar nerve mini open release
Study: NCT04687176

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral Arsenic Trioxide Formulation
Description: Patients will be recruited to oral arsenic trioxide, all-trans-retinoic acid, ascorbic acid (AAA) based-induction for 42 days. Daunorubicin or idarubicin will only be used during induction in patients \<65 with presenting white blood cell count (WBC) ≥ 10 x 10\^9/L. In patients not receiving daunorubicin, hydroxyurea if WBC ≥ 5 x 10\^9/L within the first 14 days of induction. A reassessment bone marrow aspirate will be performed on day 28 of induction for assessment of morphologic remission.~Four weeks after the completion of induction phase, all patients, regardless of initial WBC, will receive two cycles of chemotherapy-free AAA consolidation (14 days every 28 days).~Four weeks after completion of consolidation, all patients will receive 12 cycles of chemotherapy-free AAA maintenance (14 days every 8 week).
Study: NCT04384367

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rizatriptan 10 mg + Naproxen 550mg
Description: oral - single dose

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Maxalt 10Mg Tablet
Description: oral - single dose

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Flanax 550mg
Description: oral - single dose

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo oral tablet
Description: oral - single dose
Study: NCT05279404

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: electroacupuncture
Description: Electroacupuncture at Neiguan and Jianshi acupoint

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: electroacupuncture
Description: Electroacupuncture at Neiguan and Jianshi acupoint
Study: NCT05214053

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cone Beam CT
Description: Each patient will undergo a Cone Beam CT and a MDCT
Study: NCT04863521

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MHP
Description: MyHealthyPregnancy app (MHP 3.0) is a mHealth app specifically focused on detection and referral for depression and IPV (Intimate Partner Violence) risk, in addition to its other pregnancy risk detection and support features.
Study: NCT05710380

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Risk Map Decision Support System (DSS).
Description: The Risk Map DSS tool is an image analysis software that automatically interprets images of the prostate that were captured using an MR (magnetic resonance) scanner (an imaging technique that uses scanners to take pictures of the body). This tool can potentially identify additional areas of cancer in your prostate that may have otherwise been missed.

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging (MRI)
Description: A medical imaging test that uses a large machine/scanner to take images of the body and internal organs and structures.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging (MRI) Guided Biopsy
Description: A removal of tumor tissue from the body based on images of the prostate provided by a previous magnetic resonance imaging (MRI) test. Up to 2 biopsies on trial.
Study: NCT05337904

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: On-Stimulation
Description: The surgical electrode implanted in target 1 (ACC) or target 2 (NAcc) by a pulse generating device is on.

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Off-Stimulation
Description: The surgical electrode implanted in target 1 (ACC) or target 2 (NAcc) by a pulse generating device is off.
Study: NCT06482242

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: My Best Alaska Life
Description: MBAL's combination of digital innovation, inclusive content, and youth-driven design positions it as a leading-edge intervention in the field of sexual health, with the potential to significantly impact the lives of Y/YA in AK and beyond. The open-access digital website enhances the reach and engagement of MBAL, particularly among adolescents who may prefer to seek information and support online in a private, self-paced setting. By allowing youth to fill out this tool at their own pace and return to their home page as they want to reflect/change answers, they can update it as their lives change. Additionally, MBAL incorporates interactive elements (question types of open response, ranking, scales, drag/drop; journaling prompts \& space) and personalized features (ex. avatars of common AK animals designed by Y/YA), allowing users to tailor their life planning experience according to their individual needs and preferences and return to their answers.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: My Best Alaska Life
Description: MBAL's combination of digital innovation, inclusive content, and youth-driven design positions it as a leading-edge intervention in the field of sexual health, with the potential to significantly impact the lives of Y/YA in AK and beyond. The open-access digital website enhances the reach and engagement of MBAL, particularly among adolescents who may prefer to seek information and support online in a private, self-paced setting. By allowing youth to fill out this tool at their own pace and return to their home page as they want to reflect/change answers, they can update it as their lives change. Additionally, MBAL incorporates interactive elements (question types of open response, ranking, scales, drag/drop; journaling prompts \& space) and personalized features (ex. avatars of common AK animals designed by Y/YA), allowing users to tailor their life planning experience according to their individual needs and preferences and return to their answers.
Study: NCT06068400

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BCMA/GPRC5D double CAR-T
Description: BCMA/GPRC5D double CAR-T is a new type CAR-T cells therapy for patients with Multiple Myeloma.
Study: NCT06392126

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: nL-CHCHD-001
Description: Personalized antisense oligonucleotide
Study: NCT06549634

Intervention type: DRUG
Intervention: Daratumumab
Description: Daratumumab is not being administered as part of the study. Patients will receive daratumumab as part of their clinical care, and blood and urine will be collected in order to measure biomarkers pre- and post-daratumumab administration
Study: NCT05175625

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant
Description: SARS-CoV-2 recombinant spike protein (25 µg) with Advax-SM adjuvant (15 mg); a single intramuscular injection into the deltoid muscle of the non-dominant arm
Study: NCT06504745

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Peer education
Description: experimental group

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: control group
Description: instruction training
Study: NCT05175625

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Saline placebo
Description: 0.9% sodium chloride (1 mL); a single intramuscular injection into the deltoid muscle of the non-dominant arm
Study: NCT04571034

Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Sham Therapeutic Ultrasound
Description: A standard ultrasound machine (Vectratm by Chattanooga Group, Inc.) with inactive probe will be used to deliver sham massage.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Medium-Intensity Roller Massage
Description: This group will receive a single bout of roller massage at medium intensity (25 newtons of force directed perpendicular to the surface of the thigh).

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: High-Intensity Roller Massage
Description: This group will receive a single bout of roller massage at medium intensity (45 newtons of force directed perpendicular to the surface of the thigh).
Study: NCT06478095

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Visual aids
Description: Diagrams, models, and videos
Study: NCT04827238

Intervention type: DIAGNOSTIC_TEST
Intervention: Standardized Invasive Hemodynamics
Description: The SIH technique is a standardized, reproducible and efficient way of obtaining hemodynamic measurements.
Study: NCT05045183

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: SoC Adhesive Bandage
Description: On the randomized wound site, a SoC adhesive bandage will be applied.
Study: NCT04965519

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RC48-ADC
Description: 2.0mg/kg IV every 2 weeks
Study: NCT05045183

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SoC Adhesive Bandage
Description: On the randomized wound site, a SoC adhesive bandage will be applied.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SoC Adhesive Bandage
Description: On the randomized wound site, a SoC adhesive bandage will be applied.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SoC Adhesive Bandage
Description: On the randomized wound site, a SoC adhesive bandage will be applied.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Antibiotic Ointment
Description: On the randomized wound site, a antibiotic ointment will be applied.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Antibiotic Ointment
Description: On the randomized wound site, a antibiotic ointment will be applied.
Study: NCT06656143

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Traditional Physical therapy
Description: The exercise program included the strengthening of the deep cervical flexor and shoulder retractor muscles and also stretching of the pectoralis and cervical extensor muscles.~(3 sets of 12 repetitions) Strengthening Deep Cervical Flexors Lying chin tuck Lying chin tuck with head lift. Strengthening Shoulder Retractors Standing shoulder pull back with elastic Shoulder pull back with weight Stretch Cervical Extensors Chin drop Stretch Pectoralis Muscle Bilateral Pectoral stretch

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Diaphragmatic Myofascial Release
Description: To release the diaphragm, the patient was positioned in the supine position. The therapist stood at the head of the patient. The therapist made manual contact bilaterally under the costal cartilages of the lower ribs (7th to 10th) with hypothenar regions of the hands and last three fingers. During the patient's inspiration, the therapist was gently pulling the points of hands contacts toward the head and slightly laterally, while elevating the ribs simultaneously. During exhalation, the therapist deepened hand contacts towards the inner costal margins Exercise Program (3 sets of 12 reps) Strengthening deep cervical flexors Strengthening shoulder retractors Stretching Cervical Extensors Stretching Pectoralis Muscle
Study: NCT05045183

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Antibiotic Ointment
Description: On the randomized wound site, a antibiotic ointment will be applied.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Antibiotic Ointment
Description: On the randomized wound site, a antibiotic ointment will be applied.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Antiseptic Wash
Description: On the randomized wound site, a antiseptic wash will be applied.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Antiseptic Wash
Description: On the randomized wound site, a antiseptic wash will be applied.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Hydrocolloid Pad
Description: On the randomized wound site, hydrocolloid pad will be applied.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Hydrocolloid Pad
Description: On the randomized wound site, hydrocolloid pad will be applied.
Study: NCT05971420

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: VR activity-based
Description: VR games activities were chosen for simulated cognitive-motor training in the VR group. The VR training modules for this study included fire drill, walking exercise, balancing game activities and community shopping practices. These training modules involved dual task components; the participant was expected to train up his/her physical and cognitive motor performances in an 8-week VR activity-based program. VR group participants received 2-sessions per week, 16 training sessions in total.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise-based (Baduanjin)
Description: The exercise group used a traditional Chinese Qigong Baduanjin exercise incorporating with a fall prevention education strategy.
Study: NCT05549934

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-06651600
Description: tablets containing active drug (a combined JAK3/TEC inhibitor)
Study: NCT06326697

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azacitidine
Description: Azacitidine 300 mg Film coated tablets

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Onureg
Description: Azacitidine 300 mg Film coated tablets
Study: NCT06035315

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Multiple Micronutrients during pregnancy
Description: Pregnant women examine since 8 weeks gestation are being followed until delivery; are given additional micronutrients (Complete multi micronutrients-Calcium-Vitamin D-DHA); and perform ultrasound examinations each trimester and additional laboratory examination (Vitamin D level-Lipid profile-Zinc)
Study: NCT05907265

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral: ONCOBrain_ImmersiveVR
Description: A multimodal and digitally-based cognitive training, physical exercise and mindfulness intervention delivered face to face and through 360MK Virtual Reality technology

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Behavioral: Control_Condition
Description: Traditional paper or pdf format multimodal intervention that will combine cognitive, mediation and physical activities.
Study: NCT05662865

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SGLT2 inhibitor
Description: SGTL2i (15 mg) once daily

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Controlled, Adaptive Study Diet
Description: An adaptive study diet combined with SGLT2i, which consists of four sequential, 7-day long phases in which dietary carbohydrates are gradually reduced (50% carbs, 30% carbs, 20% carbs, and 10% carbs) based on safety and tolerability to achieve moderate ketosis. All diet phases are isocaloric. All meals are provided on an inpatient unit.